Video Experimental Relacionado
Updated: May 8, 2026
10:26
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
La autopropagación de los agregados proteicos patógenos en las enfermedades neurodegenerativas
Mathias Jucker1, Lary C Walker
1Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. mathias.jucker@uni-tuebingen.de
Nature
|September 6, 2013
Resumen
La investigación de la enfermedad priónica ofrece información sobre los trastornos neurodegenerativos relacionados con la edad. Comprender el mal plegamiento y la agregación de proteínas, similar a los priones, puede desbloquear nuevos tratamientos para enfermedades como el Alzheimer.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- La bioquímica es la bioquímica.
- Patología Patología Patología.
Sus antecedentes:
- Los trastornos neurodegenerativos relacionados con la edad son una preocupación significativa para la salud.
- Durante mucho tiempo se ha especulado que las enfermedades priónicas, caracterizadas por un mal plegamiento de las proteínas, contienen claves para comprender estas condiciones.
- Los recientes avances en los modelos de enfermedades han proporcionado apoyo experimental a esta hipótesis.
Objetivo del estudio:
- Explorar el papel del mal plegamiento y la agregación de proteínas similares a priones en la neurodegeneración.
- Establecer un principio patógeno unificador para una serie de enfermedades neurológicas.
- Identificar estrategias terapéuticas potenciales basadas en el paradigma del prión.
Principales métodos:
- Revisión de hallazgos experimentales recientes y modelos de enfermedades.
- Análisis de mal plegamiento de proteínas y mecanismos de agregación.
- Comparación de vías patógenas en enfermedades priónicas y otras proteopatías.
Principales resultados:
- Las proteínas específicas se doblan mal y se agregan en semillas que se propagan por sí mismas.
- Estas semillas corrompen otras proteínas, lo que lleva a ensamblajes patógenos (de oligómeros a amiloides).
- Tanto los orígenes de novo como los infecciosos de la corrupción de proteínas contribuyen al compromiso del sistema nervioso.
Conclusiones:
- El paradigma priónico ofrece un principio unificador para la comprensión de diversas enfermedades neurodegenerativas.
- Las semillas proteínicas actúan como agentes que impulsan la instigación y la progresión de la enfermedad.
- Esta comprensión sugiere direcciones terapéuticas ampliamente aplicables para condiciones neurológicas intratables como la enfermedad de Alzheimer.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...